| |
NanoCor's Team
NanoCor’s team is highly experienced in virology (AAV in particular), in the cardiovascular field and in the development of gene therapy based therapeutics. Dr. Richard Jude Samulski, the developer of the BNP™ technology, has almost 30 years of experience in rAAV and is the Director of the Gene Therapy Center at the University of North Carolina – Chapel Hill. Dr. Evangelia Kranias, the developer of the I-1 technology, is well known for her work in phospholambam and the biology of heart failure, and is the Distinguished Professor and Director of Cardiovascular Biology at the University of Cincinnati. Dr. Roger Hajjar is a leader in gene therapy techniques and model testing for cardiovascular diseases.
Management Team
Daniel C. Sigg, MD, PhD
Chief Executive Officer
Leslie Miller, MD
Chief Medical Officer
Board of Directors
Sheila A. Mikhail, J.D., M.B.A.
Founder
Jude Samulski, Ph.D.
Scientific Founder, Collaborator
Gerald L. Klein, M.D.
Board Member
Founders
Sheila A. Mikhail, J.D., M.B.A.
Founder
Gabor M. Rubanyi, M.D., Ph.D.
Founder
Scientific Collaborators
Jude Samulski, Ph.D.
Scientific Founder, Collaborator
Evangelia Kranias, Ph.D.
Scientific Founder, Collaborator
Roger Hajjar, MD, Ph.D.
Scientific Founder, Collaborator
Strategic Partners
UNC Chapel Hill
Massachusetts General Hospital/Harvard
University of Cincinnati
Mount Sinai Medical Center
Medtronic
|
|
|